Kenneth S. Cohen

University of Chicago — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

28h-index8.6kcitations135works0.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Angiogenesis and VEGF in Cancer(25), Lymphoma Diagnosis and Treatment(15), Cancer, Hypoxia, and Metabolism(10), Chronic Lymphocytic Leukemia Research(9), Immune cells in cancer(7)

Publications134 total

Healthcare utilization in patients with sickle cell disease on buprenorphine for chronic pain
Blood·2025
Prevention of Venous Thromboembolic Events
Seminars in Interventional Radiology·2025Open Access
A multicenter phase 1/2 trial of lenalidomide and dose-adjusted EPOCH-R in MYC-associated DLBCL
Blood Advances·2025· 1 citedOpen Access
Pain Management in Patients with Sickle Cell Disease through an Inpatient Sickle Cell Disease Consult Service
Blood·2024
Hematology/oncology clinical investigator training: Is current model of education adequate?
Journal of Clinical Oncology·2024· 1 cited
Implementation of a Multipronged Intervention to Improvement Inpatient Sickle Cell Disease Care
Blood·2023Open Access
Supplementary Table 1 from Critical Role for the Receptor Tyrosine Kinase EPHB4 in Esophageal Cancers
2023Open Access
Supplementary Figures 1-7 from Blockade of Tumor Necrosis Factor α Signaling in Tumor-Associated Macrophages as a Radiosensitizing Strategy
2023Open Access
Data from Critical Role for the Receptor Tyrosine Kinase EPHB4 in Esophageal Cancers
2023Open Access
Supplementary Table 1 from Critical Role for the Receptor Tyrosine Kinase EPHB4 in Esophageal Cancers
2023Open Access
Data from Blockade of Tumor Necrosis Factor α Signaling in Tumor-Associated Macrophages as a Radiosensitizing Strategy
2023Open Access
Supplementary Figures 1-7 from Blockade of Tumor Necrosis Factor α Signaling in Tumor-Associated Macrophages as a Radiosensitizing Strategy
2023Open Access
Data from Critical Role for the Receptor Tyrosine Kinase EPHB4 in Esophageal Cancers
2023Open Access
Data from Blockade of Tumor Necrosis Factor α Signaling in Tumor-Associated Macrophages as a Radiosensitizing Strategy
2023Open Access
Prospective Multi-Center Phase I/II Trial of Lenalidomide and Dose-Adjusted EPOCH-R in MYC-Associated B-Cell Lymphomas
Blood·2022
What is indigenous science?
EXPLORE·2022· 4 cited
Association of Progestogens and Venous Thromboembolism Among Women of Reproductive Age
Obstetrics and Gynecology·2022· 42 citedOpen Access
COVID-19 Pandemic and Inner City Youth E-Cigarette Use
2022
Refractory vaccine‐induced immune thrombotic thrombocytopenia (<scp>VITT</scp>) managed with delayed therapeutic plasma exchange (<scp>TPE</scp>)
Journal of Clinical Apheresis·2021· 22 cited
Phase I/II clinical trial of temsirolimus and lenalidomide in patients with relapsed and refractory lymphomas
Haematologica·2021· 26 citedOpen Access
page 1 of 7Next →

Frequent Co-authors

David T. Scadden(16), Dan G. Duda(15), Rakesh K. Jain(14), Emmanuelle di Tomaso(8), Christopher G. Willett(6), Susan Cheng(6), Martin G. Larson(6), Stanley Y. Shaw(6), Ramachandran S. Vasan(6), Thomas J. Wang(6), Rachael Klein(6), Yves Boucher(5), Roderick P. Martin(5), Elizabeth L. McCabe(5), Justin Kline(5), Lance L. Munn(4), Sergey V. Kozin(4), Gregory Y. Lauwers(4), Sonali M. Smith(4), Christopher J. O’Donnell(4)